Arcadia Biosciences, Inc. (RKDA)
USD 3.03
(5.3%)
USD 3.03
(5.3%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 19.7 Million USD | -31.87% |
| 2022 | 28.92 Million USD | -34.15% |
| 2021 | 43.91 Million USD | -7.24% |
| 2020 | 47.34 Million USD | 45.36% |
| 2019 | 32.57 Million USD | 35.59% |
| 2018 | 24.02 Million USD | 44.98% |
| 2017 | 16.57 Million USD | -70.71% |
| 2016 | 56.57 Million USD | -23.8% |
| 2015 | 74.24 Million USD | 198.29% |
| 2014 | 24.88 Million USD | 160.84% |
| 2013 | 9.54 Million USD | -28.57% |
| 2012 | 13.35 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 17.36 Million USD | 8.25% |
| 2024 Q1 | 16.04 Million USD | -18.57% |
| 2023 Q3 | 23.46 Million USD | -12.43% |
| 2023 Q2 | 26.79 Million USD | -11.88% |
| 2023 FY | 19.7 Million USD | -31.87% |
| 2023 Q4 | 19.7 Million USD | -16.03% |
| 2023 Q1 | 30.41 Million USD | 5.14% |
| 2022 Q3 | 34.47 Million USD | -1.53% |
| 2022 Q4 | 28.92 Million USD | -16.1% |
| 2022 FY | 28.92 Million USD | -34.15% |
| 2022 Q1 | 38.79 Million USD | -11.66% |
| 2022 Q2 | 35 Million USD | -9.77% |
| 2021 Q4 | 43.91 Million USD | -25.85% |
| 2021 Q3 | 59.22 Million USD | -16.34% |
| 2021 Q2 | 70.79 Million USD | -0.0% |
| 2021 Q1 | 70.8 Million USD | 49.53% |
| 2021 FY | 43.91 Million USD | -7.24% |
| 2020 Q1 | 32.24 Million USD | -1.0% |
| 2020 FY | 47.34 Million USD | 45.36% |
| 2020 Q4 | 47.34 Million USD | 39.76% |
| 2020 Q2 | 37.77 Million USD | 17.15% |
| 2020 Q3 | 33.87 Million USD | -10.33% |
| 2019 Q4 | 32.57 Million USD | -12.67% |
| 2019 FY | 32.57 Million USD | 35.59% |
| 2019 Q1 | 21.95 Million USD | -8.63% |
| 2019 Q2 | 25.34 Million USD | 15.47% |
| 2019 Q3 | 37.3 Million USD | 47.17% |
| 2018 FY | 24.02 Million USD | 44.98% |
| 2018 Q2 | 31.13 Million USD | 37.76% |
| 2018 Q1 | 22.59 Million USD | 36.39% |
| 2018 Q4 | 24.02 Million USD | -11.73% |
| 2018 Q3 | 27.21 Million USD | -12.58% |
| 2017 Q1 | 52.64 Million USD | -6.94% |
| 2017 Q2 | 48.43 Million USD | -8.01% |
| 2017 FY | 16.57 Million USD | -70.71% |
| 2017 Q3 | 18.97 Million USD | -60.82% |
| 2017 Q4 | 16.57 Million USD | -12.69% |
| 2016 Q1 | 70.1 Million USD | -5.57% |
| 2016 Q4 | 56.57 Million USD | -8.14% |
| 2016 Q3 | 61.58 Million USD | -6.27% |
| 2016 Q2 | 65.7 Million USD | -6.27% |
| 2016 FY | 56.57 Million USD | -23.8% |
| 2015 Q4 | 74.24 Million USD | -7.17% |
| 2015 FY | 74.24 Million USD | 198.29% |
| 2015 Q3 | 79.97 Million USD | -5.9% |
| 2015 Q1 | 19.42 Million USD | -21.97% |
| 2015 Q2 | 84.98 Million USD | 337.63% |
| 2014 Q3 | 26.46 Million USD | -19.42% |
| 2014 Q4 | 24.88 Million USD | -5.97% |
| 2014 Q2 | 32.84 Million USD | 0.0% |
| 2014 FY | 24.88 Million USD | 160.84% |
| 2014 Q1 | - USD | -100.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q4 | 9.54 Million USD | 0.0% |
| 2013 FY | 9.54 Million USD | -28.57% |
| 2012 FY | 13.35 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 850.62 Million USD | 97.683% |
| Muliang Viagoo Technology, Inc. | 25.09 Million USD | 21.467% |
| N2OFF, Inc. | 7.24 Million USD | -172.01% |
| Yield10 Bioscience, Inc. | 3.9 Million USD | -404.351% |